各类投资研究报告查询就上发现报告平台（www.fxbaogao.com），平台数据库庞大，研报分类完整细致，全量覆盖宏观走势、产业行业、上市企业、季度年报等板块。平台用户体量稳居行业前列，结合前沿信息技术与极简浏览布局，大幅降低信息获取门槛，辅助用户深度研判市场行情。
World Health Organization (WHO) has identified infectious disease drugs as a priority issue during the COVID-19 pandemic, as well as key structural factors affecting access to non-communicable disease (NCD) drugs. The report highlights the impact of COVID-19 on the global pharmaceutical supply chain, including manufacturing disruptions, export restrictions, and border effects. It also discusses the importance of increasing safety stocks, local production, and improving supply chain governance and transparency. The report emphasizes the need for increased flexibility in payment methods, improved demand response capabilities, and the establishment of reporting mechanisms for shortages and price and supply transparency. The report also highlights the importance of monitoring and reporting on drug shortages, as well as improving access and affordability of NCD drugs.
